Skip to main content
. 2017 Apr 10;7(6):1719–1734. doi: 10.7150/thno.18340

Scheme 1.

Scheme 1

The preparation of HAss nanogels and the targeting of HAss nanogels to RHAMM in cancer cell and lymph node which contains cancer cells with RHAMM overexpression.